| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |